Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.10 is 45% above its 5-year average of -0.18, near the high end of its 5-year range (-0.46–0.05).
46.91% above its 12-month average of -0.19.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.01.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:23:14.938Z. Historical observations retain their original dates. Historical series through 2022-03-01.
EARNINGS PER SHARE (EPS)
-0.10
EARNINGS PER SHARE (EPS) AVG TTM
-0.19
EARNINGS PER SHARE (EPS) AVG 3Y
-0.27
EARNINGS PER SHARE (EPS) AVG 5Y
-0.18
EARNINGS PER SHARE (EPS) AVG 10Y
-0.25
EARNINGS PER SHARE (EPS) AVG 15Y
-0.23
EARNINGS PER SHARE (EPS) AVG 20Y
-0.20
CURRENT VS TTM AVG
+46.91%
CURRENT VS 3Y AVG
+63.19%
CURRENT VS 5Y AVG
+44.67%
CURRENT VS 10Y AVG
+59.94%
CURRENT VS 15Y AVG
+56.22%
CURRENT VS 20Y AVG
+50.22%
OPKO Health, Inc.
Market Cap
$1.10B
Earnings Per Share (EPS)
-0.10
TTM Avg
-0.19
3Y Avg
-0.27
5Y Avg
-0.18
Market Cap
$1.10B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.05
3Y Avg
-3.05
5Y Avg
-3.05
Market Cap
$1.10B
Earnings Per Share (EPS)
0.08
TTM Avg
-1.62
3Y Avg
-0.53
5Y Avg
-0.05
Market Cap
$1.10B
Earnings Per Share (EPS)
-3.15
TTM Avg
-3.22
3Y Avg
-3.17
5Y Avg
-2.78
Market Cap
$1.11B
Earnings Per Share (EPS)
-0.93
TTM Avg
-2.25
3Y Avg
-2.35
5Y Avg
-1.62
Market Cap
$1.08B
Earnings Per Share (EPS)
-3.10
TTM Avg
-1.89
3Y Avg
-1.38
5Y Avg
-1.38
Market Cap
$1.08B
Earnings Per Share (EPS)
1.79
TTM Avg
1.65
3Y Avg
1.42
5Y Avg
1.09
Market Cap
$1.13B
Earnings Per Share (EPS)
1.69
TTM Avg
2.70
3Y Avg
2.53
5Y Avg
1.91
Market Cap
$1.13B
Earnings Per Share (EPS)
N/A
TTM Avg
-9.21
3Y Avg
-17.43
5Y Avg
-24.99
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OPKO Health, Inc. (OPK) | $1.10B | -0.10 | -0.19 | -0.27 | -0.18 |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | N/A | -3.05 | -3.05 | -3.05 |
| STAAR Surgical Company (STAA)vs › | $1.10B | 0.08 | -1.62 | -0.53 | -0.05 |
| Replimune Group, Inc. (REPL)vs › | $1.10B | -3.15 | -3.22 | -3.17 | -2.78 |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | -0.93 | -2.25 | -2.35 | -1.62 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.08B | -3.10 | -1.89 | -1.38 | -1.38 |
| IRadimed Corporation (IRMD)vs › | $1.08B | 1.79 | 1.65 | 1.42 | 1.09 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 1.69 | 2.70 | 2.53 | 1.91 |
| Nektar Therapeutics (NKTR)vs › | $1.13B | N/A | -9.21 | -17.43 | -24.99 |
| Harrow Health, Inc. (HROW)vs › | $1.13B | -0.99 | -0.32 | -0.47 | -0.45 |
Trailing EPS (TTM)
$-0.10
Forward EPS (Est.)
$-0.22
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.30 |
| 2024-12-31 | -0.08 |
| 2023-12-31 | -0.25 |
| 2022-12-31 | -0.46 |
| 2021-12-31 | -0.05 |
| 2020-12-31 | 0.05 |
| 2019-12-31 | -0.53 |
| 2018-12-31 | -0.27 |
| 2017-12-31 | -0.55 |
| 2015-12-31 | -0.06 |
| 2014-12-31 | -0.41 |
| 2013-12-31 | -0.32 |
| 2012-12-31 | -0.11 |
| 2011-12-31 | -0.01 |
| 2010-12-31 | -0.08 |
| 2009-12-31 | -0.13 |
| 2008-12-31 | -0.21 |
| 2007-12-31 | -2.09 |
| 2006-12-31 | -0.04 |
| 2005-12-31 | -0.01 |
| 2004-12-31 | -0.12 |
| 2003-12-31 | -0.37 |
| 2002-12-31 | -0.67 |
| 2001-12-31 | -0.57 |
| 2000-12-31 | -0.51 |
| 1999-12-31 | -0.44 |
| 1998-12-31 | -0.30 |
| 1997-12-31 | -0.42 |
| 1996-12-31 | -0.42 |
